Survey of antiobesity drug prescribing for obese children and young people in UK primary care

OBJECTIVES: Antiobesity drug (AOD) prescribing in children and young people (CYP) in primary care is rising with high rates of discontinuation. Little is known about prescribing in this group in terms of patient demographics and comorbidities, reasons for initiation and discontinuation, or adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Billy, Hsia, Yingfen, Kinra, Sanjay, Saxena, Sonia, Christie, Deborah, Viner, Russell M, Wong, Ian C K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862202/
https://www.ncbi.nlm.nih.gov/pubmed/29637133
http://dx.doi.org/10.1136/bmjpo-2017-000104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862202/
https://www.ncbi.nlm.nih.gov/pubmed/29637133
http://dx.doi.org/10.1136/bmjpo-2017-000104

Ejemplares similares